MétaCan
Menu
Back to cohort
Record W4312086030 · doi:10.1002/alz.069243

Biological variation of Alzheimer’s disease plasma biomarkers in healthy individuals

2022· article· en· W4312086030 on OpenAlexaff
Wagner S. Brum, William van Doorn, Nicholas J. Ashton, Laia Montoliu‐Gaya, Shorena Janelidze, Eduardo R. Zimmer, Henrik Zetterberg, Thomas K. Karikari, Oskar Hansson, Steven J.R. Meex, Anna Carobene, Kaj Blennow

Bibliographic record

VenueAlzheimer s & Dementia · 2022
Typearticle
Languageen
FieldMathematics
TopicStatistical Methods in Clinical Trials
Canadian institutionsMcGill University
Fundersnot available
KeywordsBiomarkerMedicineCoefficient of variationNeurodegenerationDiseaseOncologyInternal medicineAlzheimer's diseasePathologyBiologyStatisticsGenetics

Abstract

fetched live from OpenAlex

Abstract Background Plasma biomarkers for Alzheimer’s disease (AD) have demonstrated great performance to identify AD pathology in research cohorts, and recent studies also support their potential to monitor effects of disease‐modifying treatments. To properly interpret these biomarkers in research settings and to inform power calculations of future trials using them as surrogate outcomes, information on their physiological variability over time is needed. We conducted a 10‐week biological variation (BV) study to assess the within‐individual (CV I ; CV: coefficient of variation), between‐individual (CV G ) and analytical variability (CV A ) of blood‐based AD biomarkers. These parameters can provide the reference change value (RCV), which determines how much biomarker values must change to represent a significant abnormality‐related change, i.e . exceeding analytical and biological variation. Method Plasma samples were collected weekly for 10 weeks from 20 healthy individuals from the European Biological Variation Study (n=20; 50% female, median age 46.4). Biomarkers for tau pathology (p‐tau181), brain amyloidosis (Aβ42, Aβ40, Aβ42/40), glial activation (GFAP) and neurodegeneration (NfL) were quantified in duplicate using the Simoa technology. The CV‐ANOVA statistical method was used to compute BV estimates. To evaluate diurnal rhythm of these biomarkers, we also conducted a study with non‐demented older adults (n=24; 58‐82yo), with hourly blood collections during 26h in strictly‐controlled environmental conditions (NCT02091427). P‐tau217 (Lily) analyses are ongoing for both studies. Result Individual‐level (Figure 1) and pooled biomarker levels are shown (Figure 2), as well as BV estimates (Table 1). The 10‐week within‐individual physiological variation (CV I ) was lower for Aβ42/40 (4.3%), followed by Aβ42 (6.0%), Aβ40 (6.4%), NfL (7.9%), GFAP (9.3%) and p‐tau181 (15.8%). Between‐individual variation (CV G ) was lower for Aβ42/40 (8.8%), followed by Aβ42 (13.3%), Aβ40 (17.0%), p‐tau181 (20.5%), NfL (23.0%) and GFAP (31.5%). Analytical variation was low for all biomarkers (CV A range: 2.5‐6.6%). The RCV was higher for p‐tau181 (45.6%), followed by GFAP (31.7%), NfL (27.6%), Aβ40 (19.0%), Aβ42 (18.8%) and Aβ42/40 (15.6%). Conclusion Blood‐based AD biomarkers demonstrate good week‐to‐week stability, but their CV G and RCV’s can be rather high, with implications both for use in clinical routine (misclassification risk) and for future trial designs (high numbers of participants needed). Results for the diurnal variation study will also be presented.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.008
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: Theoretical or conceptual
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.305
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0050.008
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.407
GPT teacher head0.485
Teacher spread0.078 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designTheoretical or conceptual
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicStatistical Methods in Clinical TrialsFrench-language works237,207